GSK3B and Parkinson disease: Though the precise mechanism underlying this remains indistinct, it has been established that constitutive GSK-3β activity promotes basal AMPAR endocytosis leading to inhibition of synaptic plasticity and development of cognitive dysfunction in PD [43, 50].